Pay in 4 interest-free payments of $5.39 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
This is due to a variety of issues, from procurement, supply chain, and financial coverage, to the accessibility, affordability and availability of GLP-1 receptor agonists [which] remain highly inadequate to meet the population-level needs. Mind the evidence gap Despite the plethora of short-term evidence for GLP-1s in the management of weight loss, almost nothing is known about the possible long-term effects of these artificial peptide hormones
Psychiatry 23 , 11571168
Efficacy and safety of once-weekly tirzepatide in Japanese patients with obesity disease (SURMOUNT-J): A multicentre, randomised, double-blind, placebo-controlled phase 3 trial
doi:10.1038/s41467-020-14934-5 26
Uncontrolled hyperglycemia can cause thirst in patients with diabetes
Oh, it's for weight loss
US$ 21.95
US$ 22.33
US$ 22.84
US$ 22.66
US$ 21.80
US$ 20.42
US$ 29.58
US$ 27.39
US$ 21.79
US$ 27.55
